• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$41.11 -$0.05 (-0.12%)

REAL-TIME: Last trade at

Eli Lilly & Co.

NYSE:LLY

Jump to this page for:

Related Resources

Have J&J's Approval Hopes Vanished?

5/26/2012 by DailyFinance

Finding a Pathway to Approval

5/24/2012 by DailyFinance

Johnson & Johnson: An Uncommon Opportunity

5/24/2012 by Seeking Alpha

Healthcare Dogs Stay Steady In April

5/24/2012 by Seeking Alpha

Incyte Stays Neutral - Analyst Blog

5/24/2012 by Nasdaq

Incyte Stays Neutral - Analyst Blog

5/24/2012 by Nasdaq

Buy, Sell, or Hold: Johnson & Johnson

5/23/2012 by DailyFinance

JNJ Updates: Positives For Xarelto & Simponi

5/23/2012 by Trefis

Is Bristol a Buy Post-Plavix

5/23/2012 by DailyFinance

Are 3 Failed Phase 3 Trials Enough?

5/23/2012 by DailyFinance

Lilly's GLP-1 Agonist Delivers - Analyst Blog

5/23/2012 by Nasdaq

Eli Lilly: Diabetes Drug Meets Cardiovascular Goals

5/22/2012 by Smart Money

Has Cognex Become the Perfect Stock?

5/21/2012 by DailyFinance

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABP

5/18/2012 by 247wallst

Merck KGaA's Erbitux Faces Hurdle - Analyst Blog

5/17/2012 by Nasdaq

This Biotech's for Sale! Reportedly.

5/15/2012 by DailyFinance

Hostile Takeover? More Like Nice Guy Showdown.

5/11/2012 by DailyFinance

UPDATE: Drug Makers Refute India Allegations Of Regulatory Irregularities

5/10/2012 by Smart Money

The Best Dividends On May 11, 2012

5/10/2012 by Trefis

GlaxoSmithKline: Complied With Indian Rules In Getting Heart, Lung Drug Approved

5/10/2012 by Smart Money

A Much-Needed Win for Pfizer

5/10/2012 by DailyFinance

Mixed Quarter from Teva - Analyst Blog

5/10/2012 by Nasdaq

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CY

5/10/2012 by 247wallst

UPDATE: Teva 1Q Profit Up 13% On Branded, Generic Drug Sales

5/9/2012 by Smart Money

WSJ BLOG/Health: A.M Vitals: "Good" Cholesterol Drug Fails; Alzheimer's and Depression Linked

5/8/2012 by Smart Money

2nd UPDATE: Abbott To Pay $1.6 Billion To Settle Depakote Marketing Probes

5/7/2012 by Smart Money

WSJ BLOG/Health: A.M. Vitals: U.S. to Match Orphaned Drugs With Researchers

5/4/2012 by Smart Money

Will the FDA Approve Alexza's Adasuve?

5/3/2012 by DailyFinance

Several Arrested For 2010 Drug Theft From Eli Lilly Warehouse -Reports

5/3/2012 by Smart Money

The Best Yielding Large Cap Healthcare Dividend Stocks

5/2/2012 by Trefis

WSJ BLOG/Health: A.M. Vitals: Texas Cuts Off Funding for Planned Parenthood

5/2/2012 by Smart Money

BMW Slapped With Erection Lawsuit

5/2/2012 by Minyanville

Will Novo Nordisk Help You Retire Rich?

5/1/2012 by DailyFinance

1 Biotech Maximizing Shareholder Value

5/1/2012 by DailyFinance

This Biotech Rejects a Gift Offer

5/1/2012 by DailyFinance

1 Dividend to Buy, 1 Dividend to Sell

4/30/2012 by DailyFinance

Another Reason to Get Excited About VIVUS

4/30/2012 by DailyFinance

FDA Approves Stendra For Erectile Dysfunction

4/27/2012 by Smart Money

Come On, Amylin, Just a Little Clue?

4/27/2012 by DailyFinance

After Hours Most Active for Apr 27, 2012 : PFE, LLY, EXC, SO, FE, BX, QQQ, MSFT, YHOO, CSCO, NWSA,

4/27/2012 by Nasdaq
See More Articles...